US Patent 9006188 Co-crystals of dapagliflozin
Patent 9006188 was granted and assigned to Mapi Pharma on April, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9006188 Co-crystals of dapagliflozin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.